Adapt Pharma submits rolling NDA for intranasal treatment for opioid overdose
Adapt has partnerd with biopharmaceutical firm Lightlake Therapeutics to develop treatments for opioid overdose. In December, Lightlake has agreed to license its opioid overdose reversal treatment to a